Exceptional response to Pembrolizumab, Olaparib, and intrathecal Nivolumab in refractory Stage IV Melanoma

start of a revolution that is now changing the lives of thousands of patients with melanoma and other cancers.We are also part of MIPAC, Melanoma International Patient Advocates Coalition, reunited by the dearest Valerie Guild, and now by her dauther Samantha, President of Aim at Melanoma.Dr. Kirkwood presented me to Valerie Guild and from the start we worked in creating a net to create awareness, to guide patients and inform them about treatment options, and to help researchers in clinical trials to find a cure.She, in memory of her daughter.Me to remember my husband Pierluigi who passed at 37 years old leaving me with two little children of 12 and 9 years old.We are also part of the Global Melanoma Coalition and our main objectives are -to prevent melanoma -to inform the population and create awareness about this deadly cancer -to direct patiens to specialized Dermatologists or Oncologist (we believe in the neeed of training dermato-oncologists), and to support patients during treatments -last but not the least, we help researchers find patients eager to try new drugs or treatments not as "their last resource" but also as a way to contribute to their own good and to find a cure to melanoma. Methods:We support Patients and their Caregivers during the difficult time of taking the decision, during the treatment, with sometimes annoying side effects, and psycologically back them while being sorely tried and facing a though challenge.We use webinars, social media posts and websites to arrive to our Patients.Results: Thousands of Patients are empowered to take the right decisions Conclusions: We hope and work with a strong belief and firm conviction that together with Doctors and Patients, we could find a cure to melanoma in the near future.

Authors

Institutions

Publication Details

Journal
EJC Skin Cancer
Published
2025-01-01
DOI
https://doi.org/10.1016/j.ejcskn.2025.100630
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exceptional response to Pembrolizumab, Olaparib, and intrathecal Nivolumab in refractory Stage IV Melanoma

Bastian Schilling, Georgios Tassopoulos
EJC Skin Cancer
PARP inhibition in cancer therapy
article

Exceptional response to Pembrolizumab, Olaparib, and intrathecal Nivolumab in refractory Stage IV Melanoma

Bastian Schilling, Georgios Tassopoulos
article en

Abstract

start of a revolution that is now changing the lives of thousands of patients with melanoma and other cancers.We are also part of MIPAC, Melanoma International Patient Advocates Coalition, reunited by the dearest Valerie Guild, and now by her dauther Samantha, President of Aim at Melanoma.Dr. Kirkwood presented me to Valerie Guild and from the start we worked in creating a net to create awareness, to guide patients and inform them about treatment options, and to help researchers in clinical trials to find a cure.She, in memory of her daughter.Me to remember my husband Pierluigi who passed at 37 years old leaving me with two little children of 12 and 9 years old.We are also part of the Global Melanoma Coalition and our main objectives are -to prevent melanoma -to inform the population and create awareness about this deadly cancer -to direct patiens to specialized Dermatologists or Oncologist (we believe in the neeed of training dermato-oncologists), and to support patients during treatments -last but not the least, we help researchers find patients eager to try new drugs or treatments not as "their last resource" but also as a way to contribute to their own good and to find a cure to melanoma. Methods:We support Patients and their Caregivers during the difficult time of taking the decision, during the treatment, with sometimes annoying side effects, and psycologically back them while being sorely tried and facing a though challenge.We use webinars, social media posts and websites to arrive to our Patients.Results: Thousands of Patients are empowered to take the right decisions Conclusions: We hope and work with a strong belief and firm conviction that together with Doctors and Patients, we could find a cure to melanoma in the near future.

EJC Skin CancerVol. 3
Goethe University Frankfurt (DE), University Hospital Frankfurt (DE)
Zero hunger
Openalex Percentile: Top 90%
PARP inhibition in cancer therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Exceptional response to Pembrolizumab, Olaparib, and intrathecal Nivolumab in refractory Stage IV Melanoma — Bastian Schilling, Georgios Tassopoulos · EJC Skin Cancer (2025) | TGRS Research Map | TGRS